Astrazeneca plc - ADR

XNAS: AZN

Expensive Performer

Download real time

73.99 -0.94 (-1.25%)

3.0M XNAS Volume

XNAS 24 Mar, 2025 3:40 PM (EDT)

229,393.4

Market Cap

High in industry

0.1

Beta 1Year

Very Low volatility

Capex

AstraZeneca to invest $2.5 billion in Beijing for its sixth global R&D center See details

Insider Trading disclosures for Astrazeneca plc - ADR

The latest disclosure was made by Pascal Soriot in Astrazeneca plc - ADR where a trade of 89,962 Ords 0.25p done was reported to US exchanges on March 6, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Pascal Soriot	Executive Director,Chief Executive Officer		06 Mar 2025	89,962	377,428 (0%)	0%		0	Ords 0.25p
Pascal Soriot	Executive Director,Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	05 Mar 2025	248	287,466 (0%)	0%		0	Ords 0.25p
Aradhana Sarin	Executive Director,Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	05 Mar 2025	28	119,413 (0%)	0%		0	Ords 0.25p
Pascal Soriot	Executive Director,Chief Executive Officer		04 Mar 2025	17,357	287,218 (0%)	0%		0	Ords 0.25p
Aradhana Sarin	Executive Director,Chief Financial Officer		04 Mar 2025	2,021	119,385 (0%)	0%		0	Ords 0.25p
Tony Mok	Non-Executive Director	Purchase of securities on an exchange or from another person at price $ 126.80 per share.	19 Nov 2024	1,500	3,500 (0%)	0%	126.8	190,195	Ords 0.25p
Michel Demare	Non-Executive Director,Chairman	Purchase of securities on an exchange or from another person at price $ 100.30 per share.	15 Nov 2024	2,000	10,000 (0%)	0%	100.3	200,607	Ords 0.25p
Pascal Soriot	Executive Director,Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 102.03 per share.	14 Nov 2024	20,000	221,356 (0%)	0%	102.0	2,040,600	Ords 0.25p
Philip A J Broadley	Non-Executive Director,Senior Independent Director	Purchase of securities on an exchange or from another person at price $ 101.70 per share.	13 Nov 2024	980	8,025 (0%)	0%	101.7	99,665	Ords 0.25p
Michel Demare	Non-Executive Director,Chairman	Purchase of securities on an exchange or from another person at price $ 117.93 per share.	13 Sep 2024	2,000	8,000 (0%)	0%	117.9	235,855	Ords 0.25p
Pascal Soriot	Executive Director,Chief Executive Officer		10 Jun 2024	297,418	201,356 (0%)	0%		0	Ords 0.25p
Pascal Soriot	Executive Director,Chief Executive Officer		08 Mar 2024	105,238	498,774 (0%)	0%		0	Ords 0.25p
Pascal Soriot	Executive Director,Chief Executive Officer		05 Mar 2024	17,702	393,536 (0%)	0%		0	Ords 0.25p
Soriot Pascal	Executive Director,Chief Executive Officer		20 Feb 2024	12,345	375,834 (0%)	0%		0	Ords 0.25p

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

Insider Trading disclosures for Astrazeneca plc - ADR

The latest disclosure was made by Pascal Soriot in Astrazeneca plc - ADR where a trade of 89,962 Ords 0.25p done was reported to US exchanges on March 6, 2025.

Screeners based on Insider Trading and SAST parameters